Home >

NF2 Sources

Last Updated: 07/17/17

Neurofibromatosis Type 2 (NF2), is a condition many researchers over the years have dedicated considerable time to understand. Many sources of information hold conflicting data due to constant release of new data. NF2 Information and Services is on a mission to constantly look for new developments to help doctors and people with NF2 know what to discuss and ask before treatments.

  1. Evans, D. G., et al. "A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity." Journal of medical genetics 29.12 (1992): 841-846. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1016198/
  2. Evans, D. Gareth R. "Neurofibromatosis type 2 (NF2): a clinical and molecular review." Orphanet journal of rare diseases 4.1 (2009): 16. http://www.ojrd.com/content/4/1/16
  3. Evans, D. Gareth R., and Sarah Louise Ingham. "Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors." The application of clinical genetics 6 (2013): 53. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735038/
  4. Gerber, P. A., Antal, A. S., Neumann, N. J., Homey, B., Matuschek, C., Peiper, M., ... & Bolke, E. (2009). Neurofibromatosis. European journal of medical research, 14(3), 102. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352057
  5. Plotkin, Scott R., et al. "Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis." PloS one 7.4 (2012): e35711. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0035711
  6. Won, Hon-Kit, et al. "Merlin/NF2 regulates angiogenesis in schwannomas via a Rac1/semaphorin 3F-dependent mechanism." (2012). http://www.neoplasia.com/pdf/manuscript/v14i02/neo111600.pdf
  7. Congressionally Directed Medical Research Programs. NF2 Storyboard. (2010) http://cdmrp.army.mil/nfrp/pdf/NF2storyboard.pdf
  8. NINDS. National Institute of Neurological Disorders and Stroke. NIH Publication. "Neurofibromatosis Fact Sheet." Last modified May, 2011. http://www.ninds.nih.gov/disorders/neurofibromatosis/detail_neurofibromatosis.htm#192843162
  9. Rolton, D., Nnadi, C., & Fairbank, J. (2014). Scoliosis: a review. Paediatrics and Child Health, 24(5), 197-203. http://www.sciencedirect.com/science/article/pii/S1751722213002382
  10. Widemann, B. C., Acosta, M. T., Ammoun, S., Belzberg, A. J., Bernards, A., Blakeley, J., ... & Morrison, H. (2014). CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. American Journal of Medical Genetics Part A. http://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.36312/full
What is NF2? | About Us | Treatment Options | Sitemap

Site Search

Disclaimer: Neurofibromatosis Type 2 - Information and Services, www.nf2is.org, is not run by medical experts, affiliated with any healthcare organization or any other company. No assurance can be made to the accuracy or completeness of the information provided here, the accuracy of other sites to which this site links, or of sites that link to this site. - Read More

Copyright © 2021